FR2547503B1 - Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee - Google Patents

Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee

Info

Publication number
FR2547503B1
FR2547503B1 FR8407796A FR8407796A FR2547503B1 FR 2547503 B1 FR2547503 B1 FR 2547503B1 FR 8407796 A FR8407796 A FR 8407796A FR 8407796 A FR8407796 A FR 8407796A FR 2547503 B1 FR2547503 B1 FR 2547503B1
Authority
FR
France
Prior art keywords
administration
active agents
physiologically active
new solvent
penetration system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8407796A
Other languages
English (en)
Other versions
FR2547503A1 (fr
Inventor
Jorge Heller
Wilfred A Skinner
Kenichiro Saito
Susumu Satoh
Yumiko Takakura
Yoshiaki Itoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Publication of FR2547503A1 publication Critical patent/FR2547503A1/fr
Application granted granted Critical
Publication of FR2547503B1 publication Critical patent/FR2547503B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8407796A 1983-05-20 1984-05-18 Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee Expired FR2547503B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49673283A 1983-05-20 1983-05-20

Publications (2)

Publication Number Publication Date
FR2547503A1 FR2547503A1 (fr) 1984-12-21
FR2547503B1 true FR2547503B1 (fr) 1987-11-20

Family

ID=23973888

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8407796A Expired FR2547503B1 (fr) 1983-05-20 1984-05-18 Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee

Country Status (8)

Country Link
CA (1) CA1225594A (fr)
CH (1) CH657531A5 (fr)
DE (1) DE3418565C2 (fr)
DK (1) DK239984A (fr)
FR (1) FR2547503B1 (fr)
GB (1) GB2141025B (fr)
NL (1) NL8401422A (fr)
SE (1) SE8402561L (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4826686A (en) * 1985-12-14 1989-05-02 Boehringer Ingelheim Kg Therapeutic system
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
CA1334646C (fr) * 1988-04-08 1995-03-07 James Vanolden Peck Produits stimulant la penetration transdermique
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
WO1994021262A1 (fr) * 1993-03-17 1994-09-29 Alza Corporation Dispositif d'administration transdermique d'alprazolam
DE4432429A1 (de) * 1994-09-12 1996-03-14 Heinz Prahm Arzneimittel enthaltend S-Milchsäure und dessen Verwendung
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
US20070083186A1 (en) * 2005-09-30 2007-04-12 Darrick Carter Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158283A (en) * 1965-10-21 1969-07-16 Foster Milburn Company Composition to be Applied to Skin and Process for Preparing Same.
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
SE325667B (fr) * 1968-03-06 1970-07-06 Medisan Ab
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
CA1165240A (fr) * 1980-07-09 1984-04-10 The Procter & Gamble Company Composes pharmaceutiques a usage topique
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion

Also Published As

Publication number Publication date
SE8402561L (sv) 1984-11-21
DK239984D0 (da) 1984-05-15
DE3418565C2 (de) 1992-05-27
GB2141025B (en) 1986-09-17
CA1225594A (fr) 1987-08-18
GB8412569D0 (en) 1984-06-20
SE8402561D0 (sv) 1984-05-11
NL8401422A (nl) 1984-12-17
CH657531A5 (de) 1986-09-15
FR2547503A1 (fr) 1984-12-21
GB2141025A (en) 1984-12-12
DK239984A (da) 1984-11-21
DE3418565A1 (de) 1984-11-22

Similar Documents

Publication Publication Date Title
FR2561103B1 (fr) Systeme pour l'administration reglee de substances a des ruminants
FR2567761B1 (fr) Dispositif d'apport transdermique pour l'administration de fentanyl
FR2539627B1 (fr) Compositions succedanees evitant de fumer pour l'administration nasale
IT1169806B (it) Dispositivo per la somministrazione controllata di farmaci
AU545402B2 (en) Bandage for prolonged percutaneous drug administration
FR2547503B1 (fr) Nouveau systeme solvant-auxiliaire de penetration pour l'administration d'agents physiologiquement actifs par administration percutanee
IL71967A (en) Drug administration composition
GB2142237B (en) Pharmaceutical compositions for percutaneous administration
BE849632A (fr) Composition pharmaceutique pour l'administration orale
EP0056379A4 (fr) Compositions a liberation controlee pour administrer aux ruminants des agents therapeutiques.
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
AR245125A1 (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y sus sales de adicion de acidos farmaceuticamente aceptables.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
IT8419141A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina.
ES527201A0 (es) Procedimiento para la preparacion de derivados heterociclicos de fenilsulfonil-n'-pirimidinil- y -triacinil-ureas
IT8222566A0 (it) Derivato dell'acido ursolico farmacologicamente attivo.
ES2000714A6 (es) Un procedimiento para preparar derivados de tetrahidroisoquinoleina
IT8321080A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina.
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
GB2142238B (en) Pharmaceutical compositions for percutaneous administration
IT1185513B (it) Procedimento per l'ottenimento di preparati farmaceutici con effetto ritardato
FR2568124B1 (fr) Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
FR2602680B1 (fr) Compositions pharmaceutiques pour l'administration par voie nasale
ZA93197B (en) Methods for preventing mycrobacterial infections by administration of rifabutin

Legal Events

Date Code Title Description
ST Notification of lapse